期刊文献+

两种盐酸特比萘芬乳膏经离体小型猪皮渗透吸收的比较研究 被引量:2

The Comparative Studies on Percutaneous Absorption for Two Kind of Terbinafine Hydrochloride Cream by in vitro Tibet Minipig's Skin
暂未订购
导出
摘要 目的比较研究两家企业生产的盐酸特比萘芬乳膏对离体小型猪皮的透皮吸收性能。方法采用改良的Franz扩散池,离体小型猪皮片涂药后不同时间采样,用高效液相色谱法测定接收液和皮片中盐酸特比萘芬的浓度。结果盐酸特比萘芬乳膏透皮释放量很低,在80%乙醇生理盐水释放液中,某企业生产的乳膏产品和中关天津史克制药有限公司生产的乳膏产品在48h时累积透皮渗透量分别为55.23mg/cm2和63.33mg/cm2,48h的累积透过率分别为:1.09%、1.19%。结论两家企业生产的乳膏产品在相同渗透介质下,对于离体小型猪皮的透皮无显著性差别,二者透皮情况相当。盐酸特比萘芬乳膏主成分大部分滞留在皮肤上,只有极少数透过皮肤屏障,有利于其发挥局部治疗作用。 Objective To study the percutaneous absorption of terbinafine hydrochloride cream through in vitro Tibet minipig's skins, and compare the penetration absorption of domestic certain enterprise product with GlaxoSmithKline china product. Methods Using the modified Franz diffusion cell, samples were collected at different time after the drug was applied. The concentration of terbinafine hydrochloride in the samples was measured by HPLC. Results The penetration release quantities of terbinafine hydrochloride across Tibet minipig skins in 80% ethanol saline solution in 48h were very low, only 63.33 mg .cm-2 for GlaxoSmithKline China product, and 55.23 mg. cm-2 for certain enterprise product, and the percolation rate were 1.19% and 1.09%, respectively. Conclusion The percutaneous absorption of terbinafine hydrochloride cream was very low between two products without significant difference. The penetration absorbency through Tibet minipig skins of certain enterprise cream is similar to GlaxoSmithKline china product. The most of the main components of terbinafine hydrochloride cream remain in the surface of the skins, only a few through the skin barrier. It was more suited to local cure.
出处 《实验动物与比较医学》 CAS 2013年第1期64-68,共5页 Laboratory Animal and Comparative Medicine
关键词 盐酸特比萘芬 乳膏 透皮吸收 西藏小型猪 离体 Terbinafine hydrochloride Cream Percutaneous absorption Tibet minipig in vitro
  • 相关文献

参考文献4

二级参考文献4

  • 1刘志邦,梁君,余谨发.月桂氮酮的作用及其应用[J].药学实践杂志,1996,14(2):107-109. 被引量:3
  • 2[1]Dykes PJ, Thomas R, Lever L, Marks R. Pharmacokinetics of topically applied terbinafine: results from studies in healthy valunteer subjects and patients with pityriasis versicolor[ J]. J Dermatol Treat, 1990; 1(2): 19 - 21
  • 3[2]Balfour JA, Faulds D. Terbinafine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses[J]. Drugs, 1992; 43(2): 259 - 84
  • 4李慎秋,陈映玲,陈春梅,段逸群,石必忠.特比萘芬软膏治疗浅部真菌病的临床观察[J].同济医科大学学报,1997,26(6):494-496. 被引量:2

共引文献2

同被引文献12

  • 1温清,贺坤,郭瑞臣.盐酸奥昔布宁临床应用进展[J].中国药事,2004,18(7):445-447. 被引量:7
  • 2郭宏,刘志东,聂淑芳,潘卫三.奥沙普秦凝胶剂的体外渗透性及药效学[J].中国新药与临床杂志,2005,24(12):942-946. 被引量:3
  • 3孙建方,郑志忠,顾军,曾学思,付雯雯,毕新岭.0.05%地奈德乳膏治疗湿疹的多中心随机双盲、对照研究[J].中华皮肤科杂志,2006,39(1):26-28. 被引量:79
  • 4Phillips BM,Sanen FJ,Leeling JL,et al.The physical,animal and human pharmacologic,and toxicologic properties of desonide,a new,topically active,antiinflammatory steroid[J].Toxicol Appl Pharmacol,1971,20(4):522-537.
  • 5Parish D,Scheinfeld N.Desonide foam:a review[J].Drugs Today(Barc),2008,44(1):55-62.
  • 6Kahanek N,Gelbard C,Hebert A.Desonide:a review of formulations,efficacy and safety[J].Expert Opin Investig Drugs,2008,17(7):1097-1104.
  • 7Rosa P,Santos JD,Lehmen TF,et al.In vitro and in vivo evaluation of a desonide gel-cream photostabilized with benzophenone-3[J].Drug Dev Ind Pharm,2015,25:1-9.
  • 8Castanedo-Cazares JP,Larraga-Pinones G,Ehnis-Perez A,et al.Topical niacinamide 4%and desonide 0.05%for treatment of axillary hyperpigmentation:a randomized,double-blind,placebo-controlled study[J].Clin Cosmet Investig Dermatol,2013,6:29-36.
  • 9Trookman NS,Rizer RL.Randomized controlled trial of desonlde hydrogel 0.05%versus desonide ointment 0.05%in the treatment of mild-to-moderate atopic dermatitis[J].J Clin Aesthet Dermatol,2011,4(11):34-38.
  • 10戴维,周玲洁,黄仲义,梁建英.奥昔布宁缓释胶囊与普通片的药动学及生物等效性[J].中国临床药学杂志,2008,17(5):280-283. 被引量:3

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部